triazoles has been researched along with r-7050 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alleyne, CH; Dhandapani, KM; King, MD | 1 |
| Adhikari, P; Ayo, TE; Sugita, S; Xu, H | 1 |
2 other study(ies) available for triazoles and r-7050
| Article | Year |
|---|---|
TNF-alpha receptor antagonist, R-7050, improves neurological outcomes following intracerebral hemorrhage in mice.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Edema; Cerebral Hemorrhage; Hematoma; Male; Mice; Neuroprotective Agents; Quinoxalines; Receptors, Tumor Necrosis Factor, Type I; Triazoles; Tumor Necrosis Factor-alpha | 2013 |
TNF Production in Activated RBL-2H3 Cells Requires Munc13-4.
Topics: Animals; Cell Degranulation; Gene Knockout Techniques; Mast Cells; Membrane Proteins; Mice; Quinoxalines; Signal Transduction; Triazoles; Tumor Necrosis Factor-alpha | 2020 |